YLF-466D

YLF-466D is a newly developed AMPK activator, which inhibits platelet aggregation.

Product Specifications

CAS Number

[1273323-67-3]

Product Name Alternative

C24

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

AMPK

Type

Reference compound

Related Pathways

Epigenetics; PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ylf-466d.html

Concentration

10mM

Purity

99.02

Solubility

DMSO : ≥ 100 mg/mL

Smiles

O=C(O)C1=CC=CC(CN2C(/C(C3=C2C=CC=C3)=C(C4=CC=C(Cl)C=C4)\C5=CC=CC=C5)=O)=C1

Molecular Formula

C29H20ClNO3

Molecular Weight

465.93

Precautions

H302, H315, H319

References & Citations

[1]Liu Y, et al. Antiplatelet effect of a newly developed AMP-activated protein kinase activator YLF-466D. Eur J Pharmacol. 2015 Aug 5;760:81-7.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 1

Isoform

AMPK

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TA810303S 30 µL

LHX2 Mouse Monoclonal Antibody [Clone ID: OTI2H2]

Ask

View Details

H4360 96 Tests

T-cell surface protein tactile (CD96) Bovine ELISA Kit

Ask

View Details

134873-FITC 100 µL

TDP2 (Tyrosyl-DNA Phosphodiesterase 2, Tyr-DNA Phosphodiesterase 2, hTDP2, 5'-tyrosyl-DNA Phosphodiesterase, 5'-Tyr-DNA Phosphodiesterase, AD022, AD-022, ETS1-associated Protein 2, EAP2, ETS1-associated Protein II, EAPII, TRAF and TNF Receptor-associated Protein, TTRAP, Tyrosyl-RNA Phosphodiesterase, VPg Unlinkase) (FITC)

Ask

View Details

32-13494-100 100 µg

WFDC2 Human

Ask

View Details

sc-400619-HDR 20 µg

SHIP-1 HDR Plasmid (h)

Ask

View Details